121 related articles for article (PubMed ID: 22389439)
1. The cellular apoptosis susceptibility CAS/CSE1L gene protects ovarian cancer cells from death by suppressing RASSF1C.
Lorenzato A; Martino C; Dani N; Oligschläger Y; Ferrero AM; Biglia N; Calogero R; Olivero M; Di Renzo MF
FASEB J; 2012 Jun; 26(6):2446-56. PubMed ID: 22389439
[TBL] [Abstract][Full Text] [Related]
2. AKT activation drives the nuclear localization of CSE1L and a pro-oncogenic transcriptional activation in ovarian cancer cells.
Lorenzato A; Biolatti M; Delogu G; Capobianco G; Farace C; Dessole S; Cossu A; Tanda F; Madeddu R; Olivero M; Di Renzo MF
Exp Cell Res; 2013 Oct; 319(17):2627-36. PubMed ID: 23948303
[TBL] [Abstract][Full Text] [Related]
3. Increased cellular apoptosis susceptibility (CSE1L/CAS) protein expression promotes protrusion extension and enhances migration of MCF-7 breast cancer cells.
Tai CJ; Shen SC; Lee WR; Liao CF; Deng WP; Chiou HY; Hsieh CI; Tung JN; Chen CS; Chiou JF; Li LT; Lin CY; Hsu CH; Jiang MC
Exp Cell Res; 2010 Oct; 316(17):2969-81. PubMed ID: 20688056
[TBL] [Abstract][Full Text] [Related]
4. Cellular apoptosis susceptibility (chromosome segregation 1-like, CSE1L) gene is a key regulator of apoptosis, migration and invasion in colorectal cancer.
Alnabulsi A; Agouni A; Mitra S; Garcia-Murillas I; Carpenter B; Bird S; Murray GI
J Pathol; 2012 Dec; 228(4):471-81. PubMed ID: 22450763
[TBL] [Abstract][Full Text] [Related]
5. PHY34 inhibits autophagy through V-ATPase V0A2 subunit inhibition and CAS/CSE1L nuclear cargo trafficking in high grade serous ovarian cancer.
Salvi A; Young AN; Huntsman AC; Pergande MR; Korkmaz MA; Rathnayake RA; Mize BK; Kinghorn AD; Zhang X; Ratia K; Schirle M; Thomas JR; Brittain SM; Shelton C; Aldrich LN; Cologna SM; Fuchs JR; Burdette JE
Cell Death Dis; 2022 Jan; 13(1):45. PubMed ID: 35013112
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of CSE1L Gene in Colorectal Cancer Reduces Tumorigenesis in Vitro.
Pimiento JM; Neill KG; Henderson-Jackson E; Eschrich SA; Chen DT; Husain K; Shibata D; Coppola D; Malafa MP
Am J Pathol; 2016 Oct; 186(10):2761-8. PubMed ID: 27521996
[TBL] [Abstract][Full Text] [Related]
7. CAS (cellular apoptosis susceptibility) gene expression in ovarian carcinoma: Correlation with 20q13.2 copy number and cyclin D1, p53, and Rb protein expression.
Peiró G; Diebold J; Löhrs U
Am J Clin Pathol; 2002 Dec; 118(6):922-9. PubMed ID: 12472286
[TBL] [Abstract][Full Text] [Related]
8. alpha-TEA inhibits survival and enhances death pathways in cisplatin sensitive and resistant human ovarian cancer cells.
Yu W; Shun MC; Anderson K; Chen H; Sanders BG; Kline K
Apoptosis; 2006 Oct; 11(10):1813-23. PubMed ID: 16850165
[TBL] [Abstract][Full Text] [Related]
9. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells.
Asselin E; Mills GB; Tsang BK
Cancer Res; 2001 Mar; 61(5):1862-8. PubMed ID: 11280739
[TBL] [Abstract][Full Text] [Related]
10. hCAS/CSE1L associates with chromatin and regulates expression of select p53 target genes.
Tanaka T; Ohkubo S; Tatsuno I; Prives C
Cell; 2007 Aug; 130(4):638-50. PubMed ID: 17719542
[TBL] [Abstract][Full Text] [Related]
11. Caspase-1alpha is down-regulated in human ovarian cancer cells and the overexpression of caspase-1alpha induces apoptosis.
Feng Q; Li P; Salamanca C; Huntsman D; Leung PC; Auersperg N
Cancer Res; 2005 Oct; 65(19):8591-6. PubMed ID: 16204022
[TBL] [Abstract][Full Text] [Related]
12. CAS (CSE1L) signaling pathway in tumor progression and its potential as a biomarker and target for targeted therapy.
Jiang MC
Tumour Biol; 2016 Oct; 37(10):13077-13090. PubMed ID: 27596143
[TBL] [Abstract][Full Text] [Related]
13. Tissue-specific alternative splicing of the CSE1L/CAS (cellular apoptosis susceptibility) gene.
Brinkmann U; Brinkmann E; Bera TK; Wellmann A; Pastan I
Genomics; 1999 May; 58(1):41-9. PubMed ID: 10331944
[TBL] [Abstract][Full Text] [Related]
14. Analysis of gene expression identifies PLAB as a mediator of the apoptotic activity of fenretinide in human ovarian cancer cells.
Appierto V; Villani MG; Cavadini E; Gariboldi M; De Cecco L; Pierotti MA; Lambert JR; Reid J; Tiberio P; Colombo N; Formelli F
Oncogene; 2007 Jun; 26(27):3952-62. PubMed ID: 17213814
[TBL] [Abstract][Full Text] [Related]
15. WWOX gene expression abolishes ovarian cancer tumorigenicity in vivo and decreases attachment to fibronectin via integrin alpha3.
Gourley C; Paige AJ; Taylor KJ; Ward C; Kuske B; Zhang J; Sun M; Janczar S; Harrison DJ; Muir M; Smyth JF; Gabra H
Cancer Res; 2009 Jun; 69(11):4835-42. PubMed ID: 19458077
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells.
Puca R; Nardinocchi L; Pistritto G; D'Orazi G
Gynecol Oncol; 2008 Jun; 109(3):403-10. PubMed ID: 18395248
[TBL] [Abstract][Full Text] [Related]
17. Presence of secretory cellular apoptosis susceptibility protein in cerebrospinal fluids of patients with intracerebral hemorrhage caused by stroke and neurotrauma.
Tung JN; Tsao TY; Chen SL; Tai CJ; Shen SC; Cheng YW; Jiang MC
Neuro Endocrinol Lett; 2010; 31(3):390-8. PubMed ID: 20588233
[TBL] [Abstract][Full Text] [Related]
18. Bcl-X(L) is functionally non-equivalent for the regulation of growth and survival in human ovarian cancer cells.
Dodier P; Piché A
Gynecol Oncol; 2006 Feb; 100(2):254-63. PubMed ID: 16188300
[TBL] [Abstract][Full Text] [Related]
19. Antitumor effect of E1A in ovarian cancer by cytoplasmic sequestration of activated ERK by PEA15.
Bartholomeusz C; Itamochi H; Nitta M; Saya H; Ginsberg MH; Ueno NT
Oncogene; 2006 Jan; 25(1):79-90. PubMed ID: 16170361
[TBL] [Abstract][Full Text] [Related]
20. Programmed cell death 4 enhances chemosensitivity of ovarian cancer cells by activating death receptor pathway in vitro and in vivo.
Zhang X; Wang X; Song X; Liu C; Shi Y; Wang Y; Afonja O; Ma C; Chen YH; Zhang L
Cancer Sci; 2010 Oct; 101(10):2163-70. PubMed ID: 20735432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
